See feature articles below: (Nasdaq:LGCY)(NYSE: SDRL, WLL, CUDA, STM)

About Broad Street Alerts:
Big opportunities in Small Cap’s

Broad Street Alerts recent profiles and track record, 217% in verifiable potential gains for our members on the last 4 small cap alerts alone!

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.

April 11th, 2016 – (NASDAQ: FNJN) called at $1.07/share hit $1.76/share in 3 days for 64% gains for our members.
These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.
–Report on:(Nasdaq:LGCY)(NYSE: SDRL, WLL, CUDA, STM)

Although the three major indexes are in the red this morning due to several negative tech earnings reports released after the market close yesterday, the shares of Whiting Petroleum Corp (NYSE:WLL), Seadrill Ltd (NYSE:SDRL), Legacy Reserves LP (NASDAQ:LGCY), Barracuda Networks Inc (NYSE:CUDA), and STMicroelectronics NV (ADR) (NYSE:STM) are not feeling any ill effects from the broader market dip, with each enjoying strong gains today. Let’s find out why traders are bidding these five stocks up and see how the smart money is positioned in each of them.

At Insider Monkey, we track around 785 hedge funds and institutional investors. Through extensive backtests, we have determined that imitating some of the stocks that these investors are collectively bullish on, can help retail investors generate double digits of alpha per year. The key is to focus on the small-cap picks of these funds, which are usually less followed by the broader market and allow for larger price inefficiencies (see the details here).

Crude Oil Optimism Sends Shares of Whiting, Seadrill, and Legacy Reserves Higher

Whiting Petroleum Corp (NYSE:WLL), Seadrill Ltd (NYSE:SDRL), and Legacy Reserves LP (NASDAQ:LGCY) are 6.6%, 6.4%, and 20.6% higher on the back of renewed crude oil optimism. Crude prices have surged since mid-February as U.S oil production has declined and various OPEC countries have run into supply transportation difficulties. Helping sentiment was yesterday’s bullish API report, which showed inventory falling rather than rising. Unfortunately, today’s more accurate EIA report showed crude inventories rising by 2 million barrels, gasoline inventories increasing by 1.6 million barrels, and distillates falling by 1.7 million barrels last week. Although those numbers, with the exception of gasoline, were better than expected, they weren’t as bullish as the API report. The short and intermediate-term for crude oil still looks promising however, and that’s good for oil and gas E&Ps and energy service companies.
Whiting Petroleum Corp (NYSE:WLL) was held by 40 elite funds that we track, out of a total of 786 as of the end of December. Those 40 funds owned more than 22% of Whiting’s float. Whiting is expected to release its latest quarterly earnings results later today.

Source: Insider Monkey
Broad street alerts has not been compensated for the mention of any publicly traded companies in this article nor do we own positions in any of the companies in this article.

Broad Street Alerts was previously compensated eighteen thousand five hundred dollars by star media llc for the mention of FNJN however, that contract has expired.

See feature articles below:

 

About Broad Street Alerts:

Big opportunities in Small Cap’s

 

Broad Street Alerts recent profiles and track record, 217% in verifiable potential gains for our members on the last 4 small cap alerts alone!

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.

April 11th, 2016 – (NASDAQ: FNJN) called at $1.07/share hit $1.76/share in 3 days for 64% gains for our members.

These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

 

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.

 

Article for BioPharmX Corporation

MENLO PARK, Calif., April 25, 2016 /PRNewswire/ — BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today announced that it has completed enrollment for its Phase 2a study of the novel topical minocycline gel BPX-01.

The Phase 2a study will assess the safety of BPX-01 in 30 patients randomized to 30 days of treatment with either BPX-01 or a placebo.  The endpoints of this study include reduction of Propionibacterium acnes (P. acnes) and cutaneous tolerance of the BPX-01 formulation.

“This research is important to the dermatology community, which has been searching for an effective alternative to current oral antibiotic acne treatments,” saidAnnaMarie Daniels, executive vice president of clinical and regulatory affairs for BioPharmX. “Our preclinical tests show the potential of BPX-01, which we believe may be able to offer dermatologists a safe, effective treatment for one of the most common skin conditions in the world.”

Nonclinical studies show the unique BPX-01 topical gel formulation of minocycline can penetrate the epidermis to deliver the antibiotic to the dermis layer of skin where the condition develops. BPX-01 is the first and only stable hydrophilic (non-oil-based) topical gel with fully solubilized minocycline, the antibacterial and anti-inflammatory medicine most commonly prescribed to treat acne vulgaris. It is anticipated that BPX-01 may effectively treat acne with lower, and therefore potentially safer, dosages of the antibiotic.

The FDA has previously found oral minocycline to be safe. However, the high dosage required to make the oral version effective against acne often causes undesirable side effects.  BPX-01 is highly anticipated by the dermatology community as a break-through alternative to the oral products currently available.

Phase 2a is expected to end by mid-year.

About BioPharmX® Corporation
BioPharmX Corporation (NYSE MKT: BPMX) is a Silicon Valley-based specialty pharmaceutical company that seeks to provide products through proprietary platform technologies for prescription, over-the-counter and supplement applications in dermatology and women’s health. To learn more about BioPharmX, visitwww.BioPharmX.com.

Forward-Looking Statement
The information in this press release contains forward-looking statements and information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” created by those sections. This press release contains forward-looking statements about the company’s expectations, plans, intentions and strategies, including, but not limited to, statements regarding, enrollment and results of the company’s Phase 2a study of BPX-01, the completion date of the Phase 2a study and the effectiveness of the BPX-01 formulation. These forward-looking statements may be identified by words such as “plan”, “expect,” “anticipate,” “believe,” or similar expressions that are intended to identify such forward-looking statements. These forward-looking statements involve risks and uncertainties, as well as assumptions, which, if they do not fully materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. The risks and uncertainties include those described in the company’s filings with the Securities and Exchange Commission. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included in this news release are made only as of the date hereof and the company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

 

Source – BPMX Press Release

 

 

 

 

 

 

Broad street alerts has not been compensated for the mention of any publicly traded companies in this article nor do we own positions in any of the companies in this article.

 

Broad Street Alerts was previously compensated eighteen thousand five hundred dollars by star media llc for the mention of FNJN however, that contract has expired.

Big opportunities in Small Cap’s

Broad Street Alerts recent profiles and track record, 217% in verifiable potential gains for our members on the last 4 small cap alerts alone!

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.

April 11th, 2016 – (NASDAQ: FNJN) called at $1.07/share hit $1.76/share in 3 days for 64% gains for our members.
These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.
–Report on:(Nasdaq: AMRS )

What: Shares of Amyris Inc. (NASDAQ:AMRS) jumped as much as 34% in early trading today after announcing a major supply agreement. But by midday on Wall Street, shares had settled to a more muted 7% gain.

So what: Amyris said it has signed a five-year Biofene supply agreement with an unnamed “global nutraceuticals company.” This replaces a one-year purchase agreement announced earlier this year and is expected to add $9 million to 2016 revenue with minimum purchase commitments in subsequent years. In total, the agreement is expected to be worth more than $100 million in revenue.

Longview
Now what: These kind of agreements should be what grows Amyris’ business long term and that’s what investors were buying into this morning. But the company has also made promising statements about growth in the past that haven’t come true.

At the end of the day, I think investors should view this announcement as an incremental positive for Amyris. But until the company proves that these contracts will drive real revenue and get to cash flow breakeven, I would be leery about betting too big on a recovery in the stock. The growth story in industrial biosciences is phenomenal, but until that story starts becoming a reality, it’s still a high-risk investment.

Source: The Motley Fool
Broad street alerts has not been compensated for the mention of any publicly traded companies in this article nor do we own positions in any of the companies in this article.

Broad Street Alerts was previously compensated eighteen thousand five hundred dollars by star media llc for the mention of FNJN however, that contract has expired.

See feature articles below:

About Broad Street Alerts:
Big opportunities in Small Cap’s

Broad Street Alerts recent profiles and track record, 217% in verifiable potential gains for our members on the last 4 small cap alerts alone!

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.

April 11th, 2016 – (NASDAQ: FNJN) called at $1.07/share hit $1.76/share in 3 days for 64% gains for our members.
These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.
–Report on:(Nasdaq: AREX )

Approach Resources Inc. (NASDAQ:AREX) – Stock analysts at SunTrust dropped their Q1 2016 earnings per share (EPS) estimates for Approach Resources in a research note issued on Monday, according to Zacks Investment Research. SunTrust analyst N. Dingmann now anticipates that the brokerage will earn ($0.34) per share for the quarter, down from their previous forecast of ($0.32). The consensus estimate for Approach Resources’ Q1 2016 earnings is ($0.33) per share. SunTrust also issued estimates for Approach Resources’ Q3 2016 earnings at ($0.28) EPS, FY2016 earnings at ($1.18) EPS, Q1 2017 earnings at ($0.22) EPS and Q3 2017 earnings at ($0.21) EPS.

Source: American Banking and Market News
Broad street alerts has not been compensated for the mention of any publicly traded companies in this article nor do we own positions in any of the companies in this article.

Broad Street Alerts was previously compensated eighteen thousand five hundred dollars by star media llc for the mention of FNJN however, that contract has expired.

See feature article on LGCY below

About Broad Street Alerts:
Big opportunities in Small Cap’s

 

Broad Street Alerts recent profiles and track record, 217% in verifiable potential gains for our members on the last 4 small cap alerts alone!

 

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.

April 11th, 2016 – (NASDAQ: FNJN) called at $1.07/share hit $1.76/share in 3 days for 64% gains for our members.
These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.

 

 

Will Legacy Reserves hit or miss earnings?

Investors will be waiting to see if the company hits or misses earnings projections after the next earnings release. Legacy Reserves LP (NASDAQ:LGCY) is slated to next post quarterly results on or around 2016-05-04. The company most recently reported earnings of $-0.33 against the Zacks Research consensus estimate of $-0.38 for the period ending on 2016-03-31. The result created a surprise factor of 13.16%, a difference of $0.05. A large surprise factor may trigger significant stock price swings immediately after an earnings report, or in the following days and weeks. As the next earnings date approaches, analysts may modify their models based on company announcements and Street sentiment. These have the ability be key indicators looking at whether results will meet or beat consensus projections.

Adding in past earnings trends, future earnings predictions and company issued and projected guidance, many covering analysts will also project future target numbers for the stocks they are tracking. These reports are sent to institutions to help assist with making investment decisions. These numbers are also available through different platforms to retail investors. As of this writing, the consensus price target (1 year) on shares of Legacy Reserves LP (NASDAQ:LGCY) stands at $1. This is based on 4 covering analysts tracked by Zacks Research. The analyst with the most positive view has the stock hitting $1, while the lowest target projection sees the stock hitting $1.

Checking on recommendations, 0 analysts have rated the stock a Strong Buy, 0 have rated it a Buy rating, 5 a Hold and 1 a Sell. All of these recommendations can be placed on a ratings scale from 1 to 5 to get to an average broker rating. A low number (1-2) indicates a consensus Buy, a middle number (2.5-3.5) indicates a Hold and any number over 4 would indicate a consensus Sell rating. At the time of writing Legacy Reserves LP shares have a consensus rating of 3.43.

 

 

Legacy Reserves LP Schedules Conference Call to Report First Quarter 2016 Results

MIDLAND, Texas, April 20, 2016 (GLOBE NEWSWIRE) — Legacy Reserves LP (“Legacy”) (Nasdaq: LGCY) will provide details of its first quarter 2016 operating and financial performance with its earnings report which is scheduled to be released on Wednesday, May 4, 2016, following the close of NASDAQ trading. A teleconference and webcast will be held on Thursday, May 5, 2016, beginning at 9:00 a.m. Central Time. Those wishing to participate in the conference call should dial 877-266-0479. A replay of the call will be available through Thursday, May 12, 2016, by dialing 855-859-2056 or 404-537-3406 and entering replay code 86768701. Those wishing to listen to the live or archived webcast via the Internet should go to the Investor Relations tab of our website at www.LegacyLP.com.

About Legacy Reserves LP

Legacy Reserves LP is a master limited partnership headquartered in Midland, Texas, focused on the acquisition and development of oil and natural gas properties primarily located in the Permian Basin, East Texas, Mid-Continent and Rocky Mountain regions of the United States. Additional information is available at www.LegacyLP.com.

CONTACT: Legacy Reserves LP
Dan Westcott
Executive Vice President and Chief Financial Officer
432-689-5200

 

 

Analyst Ratings Summary for LGCY

 

3/28/2016	Robert W. Baird	Lower Price Target	Outperform -> Neutral	$25.00 -> $9.00
2/18/2016	Wells Fargo	Downgrade	Market Perform -> Underperform
2/12/2016	Ladenburg Thalmann	Downgrade	Buy -> Neutral
1/27/2016	FBR & Co.	Downgrade	Outperform -> Market Perform	$3.00 -> $3.00
12/18/2015	Barclays	Reiterated Rating	Hold
12/7/2015	Stifel Nicolaus	Downgrade	Buy -> Hold
11/18/2015	FBR & Co.	Lower Price Target	Outperform	$8.00 -> $6.00
10/21/2015	Bank of America	Downgrade	Neutral -> Underperform	$12.00 -> $4.00
10/14/2015	Wunderlich	Downgrade	Buy -> Hold	$13.00 -> $6.00
10/12/2015	FBR & Co.	Reiterated Rating	Outperform	$8.00 -> $14.00
10/1/2015	Barclays	Reiterated Rating	Hold
9/30/2015	Barclays	Lower Price Target	Equal Weight	$9.00 -> $3.00
9/14/2015	Citigroup Inc.	Lower Price Target	Neutral	$9.50 -> $4.00
8/13/2015	JPMorgan Chase & Co.	Boost Price Target		$9.00 -> $12.00
8/12/2015	Oppenheimer	Downgrade	Market Perform -> Underperform
8/7/2015	RBC Capital	Reiterated Rating	Sector Perform	$13.00 -> $11.00
8/7/2015	Wunderlich	Lower Price Target	Buy	$14.00 -> $13.00
6/15/2015	Wunderlich	Initiated Coverage	Buy	$15.00 -> $14.00
5/8/2015	MLV & Co.	Set Price Target	Buy	$14.00
4/21/2015	Stifel Nicolaus	Boost Price Target	Buy	$14.00 -> $15.00
4/1/2015	JPMorgan Chase & Co.	Lower Price Target	Neutral	$12.00 -> $10.00
3/26/2015	Citigroup Inc.	Lower Price Target	Neutral	$22.50 -> $9.50
2/27/2015	MLV & Co.	Set Price Target	Buy	$14.00
2/27/2015	MLV & Co.	Reiterated Rating	Buy	$14.00
2/4/2015	Barclays	Reiterated Rating	Equal Weight	$9.00
1/22/2015	Raymond James	Downgrade	Outperform -> Market Perform	$20.00
12/19/2014	JPMorgan Chase & Co.	Downgrade	Overweight -> Neutral	$27.00 -> $14.00
12/17/2014	RBC Capital	Downgrade	Outperform -> Sector Perform	$28.00 -> $13.00
12/16/2014	Robert W. Baird	Downgrade	Outperform -> Neutral	$25.00 -> $9.00
12/15/2014	Oppenheimer	Downgrade	Outperform -> Market Perform	$27.00
12/8/2014	Wells Fargo	Downgrade	Outperform -> Market Perform
11/19/2014	Citigroup Inc.	Lower Price Target	Neutral	$32.50 -> $22.50
11/3/2014	Bank of America	Upgrade	Neutral -> Buy
10/31/2014	RBC Capital	Downgrade	Top Pick -> Outperform	$36.00 -> $28.00
10/31/2014	MLV & Co.	Lower Price Target	Hold	$30.00 -> $28.00
10/30/2014	Stifel Nicolaus	Reiterated Rating	Buy	$33.00 -> $27.00
10/6/2014	Wunderlich	Upgrade	Hold -> Buy	$31.00
7/29/2014	Citigroup Inc.	Downgrade	Buy -> Neutral	$27.00 -> $32.50
6/12/2014	Raymond James	Reiterated Rating	Outperform	$29.00 -> $32.00
5/28/2014	RBC Capital	Upgrade	Outperform -> Top Pick	$31.00 -> $36.00
5/27/2014	JPMorgan Chase & Co.	Upgrade	Underweight -> Neutral	$25.00 -> $29.00
5/20/2014	Wunderlich	Boost Price Target	Hold	$26.00 -> $31.00
5/9/2014	Robert W. Baird	Boost Price Target		$30.00 -> $37.00
5/7/2014	Oppenheimer	Upgrade	Market Perform -> Outperform	$29.00
5/7/2014	Robert W. Baird	Upgrade	Neutral -> Outperform	$30.00
5/5/2014	Bank of America	Reiterated Rating	Neutral	$28.00

 

 

 

Sources- Finviz, Franklin Independent, Marketbeat and Broad Street

 

 

 

Broad street alerts has not been compensated for the mention of any publicly traded companies in this article nor do we own positions in any of the companies in this article.

Broad Street Alerts was previously compensated eighteen thousand five hundred dollars by star media llc for the mention of FNJN however, that contract has expired.